UBS Group Increases Tenet Healthcare (NYSE:THC) Price Target to $150.00
Tenet Healthcare (NYSE:THC – Free Report) had its price target raised by UBS Group from $137.00 to $150.00 in a research report report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft upped their price objective […]